Virtu Financial LLC Buys New Position in Cardinal Health, Inc. (NYSE:CAH)

Virtu Financial LLC bought a new stake in Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,422 shares of the company’s stock, valued at approximately $244,000.

A number of other large investors have also recently made changes to their positions in CAH. Aaron Wealth Advisors LLC lifted its position in Cardinal Health by 1.2% during the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company’s stock worth $844,000 after acquiring an additional 97 shares during the period. Schechter Investment Advisors LLC lifted its position in Cardinal Health by 4.1% during the 4th quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company’s stock worth $250,000 after acquiring an additional 98 shares during the period. J. W. Coons Advisors LLC lifted its position in Cardinal Health by 0.6% during the 4th quarter. J. W. Coons Advisors LLC now owns 16,680 shares of the company’s stock worth $1,681,000 after acquiring an additional 100 shares during the period. Hexagon Capital Partners LLC lifted its position in Cardinal Health by 53.6% during the 4th quarter. Hexagon Capital Partners LLC now owns 338 shares of the company’s stock worth $34,000 after acquiring an additional 118 shares during the period. Finally, Synovus Financial Corp lifted its position in Cardinal Health by 0.3% during the 3rd quarter. Synovus Financial Corp now owns 54,076 shares of the company’s stock worth $4,695,000 after acquiring an additional 140 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Cardinal Health stock opened at $104.63 on Friday. The stock has a fifty day moving average of $100.44 and a two-hundred day moving average of $104.71. The company has a market capitalization of $25.48 billion, a price-to-earnings ratio of 46.50, a PEG ratio of 1.18 and a beta of 0.64. Cardinal Health, Inc. has a fifty-two week low of $85.11 and a fifty-two week high of $116.04.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.13. The company had revenue of $54.90 billion during the quarter, compared to the consensus estimate of $56.05 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. Cardinal Health’s revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.74 earnings per share. On average, analysts forecast that Cardinal Health, Inc. will post 7.35 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be issued a dividend of $0.5056 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Monday, July 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.93%. Cardinal Health’s dividend payout ratio (DPR) is 88.89%.

Analysts Set New Price Targets

A number of research firms have weighed in on CAH. Robert W. Baird decreased their price objective on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating for the company in a research report on Friday, May 3rd. Wells Fargo & Company reduced their price target on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a report on Monday, April 29th. Leerink Partnrs reissued an “outperform” rating on shares of Cardinal Health in a report on Monday, February 26th. Argus reduced their price target on Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. Finally, Evercore ISI raised their price target on Cardinal Health from $110.00 to $115.00 and gave the company an “in-line” rating in a report on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $109.67.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.